Search Results
10
Everything
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury
February 27, 2025 08:00 ET
|
Tiziana Life Sciences Ltd.
Traumatic brain injury is a leading cause of death and disabilityCurrently, there is no treatment to prevent the long-term effects of traumatic brain injuryFindings could translate into treating...
[Latest] Global Neurostimulation Device Market Size/Share Worth USD 22,299.61 Million by 2034 at a 11.98% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
February 26, 2025 11:30 ET
|
Custom Market Insights
Austin, TX, USA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neurostimulation Device Market Size, Trends and Insights By Product (Spinal Cord...
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
February 21, 2025 08:00 ET
|
Firefly Neuroscience, Inc.
KENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
Firefly Neuroscience Accepted into NVIDIA Connect Program
February 11, 2025 07:45 ET
|
Firefly Neuroscience, Inc.
Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform For the first time, Firefly also unveils a new strategic...
Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics
February 07, 2025 07:30 ET
|
Firefly Neuroscience, Inc.
- University of Waterloo’s Faculty of Engineering Recognizes Dr. Wilson with Faculty Research Excellence Award - - Esteemed researchers and engineers like Dr. Wilson are currently helping Firefly...
Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved by UKCA for NHS & Private UK Clinics
December 05, 2024 04:02 ET
|
Magstim EGI
UKCA Approves Magstim Horizon Inspire TMS for NHS & Private UK Clinics. UK Made System for Patient Treatment of MDD, OCD and Decreasing Anxiety.
Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder
November 13, 2024 08:52 ET
|
Aviv Clinics
ORLANDO, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain health clinics in the world, shares the results of a groundbreaking study revealing a specialized...
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brain Aging
September 18, 2024 11:07 ET
|
Io Therapeutics, Inc.
Io Therapeutics, Inc., presented on IRX4204 for treatment of brain aging, at the FASEB Conference on Cellular and Molecular Mechanisms of Brain Aging
Aviv Clinics Congratulates Peter Paltchik on Winning Bronze at the 2024 Paris Olympics
August 22, 2024 09:00 ET
|
Aviv Clinics
ORLANDO, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain and performance clinics in the world, congratulates Peter Paltchik on his bronze medal win in the Men’s...
Pacific Software Inc. Obtaining Quotes for the Manufacturing Cycle for Scientifically Tested Medical Food Cocktail Focused on Memory Health
June 28, 2024 18:43 ET
|
Pacific Software Inc.
Pacific Software Inc. expands into memory health with SuppleMEM AD™ and A.L.Z. Defense™. USA and Mexico distribution is planned for Q3 2024.